TY - JOUR
T1 - Injection laryngoplasty with calcium phosphate cement
AU - Shiotani, Akihiro
AU - Okubo, Keisuke
AU - Saito, Koichiro
AU - Fujimine, Takekatsu
AU - Tomifuji, Masayuki
AU - Ikeda, Asako
AU - Araki, Koji
AU - Momoshima, Suketaka
PY - 2009/6
Y1 - 2009/6
N2 - Objective: To assess the feasibility of injection laryngoplasty with calcium phosphate cement (CPC), which is an injectable paste, self-hardening, and which recrystallizes to calcium hydroxylapatite after injection. Study Design: A case series with planned data collection. Methods: Fifty-six patients with unilateral vocal fold paralysis, who received injection laryngoplasty with CPC between August 2003 and August 2007 with a minimum follow-up period of six months, were enrolled in this study. Volumetric and migration analysis for injected CPC were performed using CT after surgery. Vocal function was also assessed by GRBAS subjective voice assessment scale and maximum phonation time (MPT), acoustic analysis including period perturbation quotient (PPQ), amplitude perturbation period (APQ), and noise-to-harmonics ratio (NHR). Results: No remarkable migration or absorption of injected CPC was observed on CT up to two years after surgery. The average remaining volume of CPC was 87.8% ± 5.3% two years after injection compared to immediately after injection. Significant improvements in GRBAS scales, MPT, PPQ, APQ, and NHR were observed postoperatively. No adverse effects were observed. Conclusions: Our clinical experience revealed that CPC was safe, nonabsorbable, and effective. Injection laryngoplasty with CPC may be a useful option in the treatment of glottic insufficiency.
AB - Objective: To assess the feasibility of injection laryngoplasty with calcium phosphate cement (CPC), which is an injectable paste, self-hardening, and which recrystallizes to calcium hydroxylapatite after injection. Study Design: A case series with planned data collection. Methods: Fifty-six patients with unilateral vocal fold paralysis, who received injection laryngoplasty with CPC between August 2003 and August 2007 with a minimum follow-up period of six months, were enrolled in this study. Volumetric and migration analysis for injected CPC were performed using CT after surgery. Vocal function was also assessed by GRBAS subjective voice assessment scale and maximum phonation time (MPT), acoustic analysis including period perturbation quotient (PPQ), amplitude perturbation period (APQ), and noise-to-harmonics ratio (NHR). Results: No remarkable migration or absorption of injected CPC was observed on CT up to two years after surgery. The average remaining volume of CPC was 87.8% ± 5.3% two years after injection compared to immediately after injection. Significant improvements in GRBAS scales, MPT, PPQ, APQ, and NHR were observed postoperatively. No adverse effects were observed. Conclusions: Our clinical experience revealed that CPC was safe, nonabsorbable, and effective. Injection laryngoplasty with CPC may be a useful option in the treatment of glottic insufficiency.
UR - http://www.scopus.com/inward/record.url?scp=65649129347&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=65649129347&partnerID=8YFLogxK
U2 - 10.1016/j.otohns.2009.01.040
DO - 10.1016/j.otohns.2009.01.040
M3 - Article
C2 - 19467396
AN - SCOPUS:65649129347
SN - 0194-5998
VL - 140
SP - 816
EP - 821
JO - Otolaryngology - Head and Neck Surgery
JF - Otolaryngology - Head and Neck Surgery
IS - 6
ER -